Experiment 1020306

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE

Compounds isolated

RETRONECINE,9-O-((DL)-2-HYDROXY-2-PHENYL-BUTYRYL): N-OXIDE

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIP
OrganismEmpty organism
CitationGELBAUM,LT: GORDON,MM: MILES,M: ZALKOW,LH:. (1982). SEMISYNTHETIC PYRROLIZIDINE ALKALOID ANTITUMOR AGENTS.. 47()
Amount utilized
Compound isolated
Dose amount300.0 MG
Number2
Percent yield66%
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE
Expression resultILS